Advanced Characterization of DNA Molecules in rAAV Vector Preparations by Single-stranded Virus Next-generation Sequencing

Archive ouverte

Lecomte, Emilie | Tournaire, Benoit | Cogné, Benjamin | Dupont, Jean-Baptiste | Lindenbaum, Pierre | Martin-Fontaine, Mélanie | Broucque, Frédéric | Robin, Cécile | Hebben, Matthias | Merten, Otto-Wilhelm | Blouin, Véronique | François, Achille | Redon, Richard | Moullier, Philippe | Leger, Adrien

Edité par CCSD ; Elsevier -

International audience. Recent successful clinical trials with recombinant adeno-associated viral vectors (rAAVs) have led to a renewed interest in gene therapy. However, despite extensive developments to improve vector-manufacturing processes, undesirable DNA contaminants in rAAV preparations remain a major safety concern. Indeed, the presence of DNA fragments containing antibiotic resistance genes, wild-type AAV, and packaging cell genomes has been found in previous studies using quantitative polymerase chain reaction (qPCR) analyses. However, because qPCR only provides a partial view of the DNA molecules in rAAV preparations, we developed a method based on next-generation sequencing (NGS) to extensively characterize single-stranded DNA virus preparations (SSV-Seq). In order to validate SSV-Seq, we analyzed three rAAV vector preparations produced by transient transfection of mammalian cells. Our data were consistent with qPCR results and showed a quasi-random distribution of contaminants originating from the packaging cells genome. Finally, we found single-nucleotide variants (SNVs) along the vector genome but no evidence of large deletions. Altogether, SSV-Seq could provide a characterization of DNA contaminants and a map of the rAAV genome with unprecedented resolution and exhaustiveness. We expect SSV-Seq to pave the way for a new generation of quality controls, guiding process development toward rAAV preparations of higher potency and with improved safety profiles.

Suggestions

Du même auteur

Short-lived recombinant adeno-associated virus transgene expression in dystrophic muscle is associated with oxidative damage to transgene mRNA

Archive ouverte | Dupont, Jean-Baptiste | CCSD

International audience. Preclinical gene therapy strategies using recombinant adeno-associated virus (AAV) vectors in animal models of Duchenne muscular dystrophy have shown dramatic phenotype improvements, but long...

Accurate Identification and Quantification of DNA Species by Next Generation Sequencing in Adeno-Associated Viral Vectors Produced in Insect Cells

Archive ouverte | Penaud-Budloo, Magalie | CCSD

Accurate Identification and Quantification of DNA Species by Next Generation Sequencing in Adeno-Associated Viral Vectors Produced in Insect Cells. 20. Annual Meeting of the American-Society-of-Gene-and-Cell-Therapy (ASGCT)

NGS library preparation may generate artifactual integration sites of AAV vectors

Archive ouverte | Cogné, Benjamin | CCSD

International audience

Chargement des enrichissements...